“…As a global pediatric concern, congenital heart defects comprise a wide spectrum of cardiovascular developmental defects, which are categorized into >25 distinct clinical subtypes, including tetralogy of Fallot (TOF) (1). Although certain minor congenital heart defects spontaneously resolve, severe congenital heart disease may lead to poor health and quality of life (5)(6)(7)(8), diminished physical exercise capacity (9)(10)(11)(12)(13), impaired neurodevelopment (the most prevalent extracardiac manifestation in patients with a congenital heart defect) and brain damage (14)(15)(16)(17)(18), thromboembolic complications (19)(20)(21), acute renal injury and chronic kidney disease (22)(23)(24), hepatic dysfunction (25), pulmonary arterial hypertension (26)(27)(28), infective endocarditis (29)(30)(31), congestive cardiac failure (32)(33)(34), miscellaneous cardiac dysrhythmia (35)(36)(37) and cardiovascular demise (38)(39)(40). Improvement has been made in cardiovascular surgery and transcatheter interventional treatment, which has allowed >90% of children with congenital heart defects to survive to adulthood; adults living with various congenital heart defects outnumber children affected by congenital heart defects (41)…”